ACR Leaders at World Health Expo
ACR leaders presented at WHX Dubai on global AI, quality and safety initiatives advancing high-quality imaging and safe AI adoption worldwide.
Read more
ACR Data Science Institute’s AI Central has been updated with three new Transparent-AI products and three new products to the directory.
Three new products were added to our Transparent-AI program, which is designed to increase transparency in imaging AI and help end users have better informed discussions and selection criteria when making decisions about which algorithm might be most appropriate for their local target population.
Perspectum Diagnostics Ltd. joined the Transparent-AI program with their products MRCP+, Hepatica, and LiverMultiScan.
Transparent-AI consists of voluntarily provided data elements solicited from participating imaging AI manufacturers who currently have an FDA-cleared product in the U.S. market. Manufacturers who participate in this program will receive the Transparent-AI badge on their product listing.
Our AI Central directory has also been updated with three new products. This information is pulled directly from FDA 510K documents and updated by ACR staff. With this latest update, we see newly cleared FDA products designed for pediatric x-rays, chest CTs and prostate MR images.
New products include:
EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100)
Cardiac CT Function Software Application
ACR Leaders at World Health Expo
ACR leaders presented at WHX Dubai on global AI, quality and safety initiatives advancing high-quality imaging and safe AI adoption worldwide.
Read more
ACR Active in February CPT Editorial Panel Discussions
Radiology representatives reviewed CPT proposals, engaged with specialty groups, and advanced AI‑focused economic insights at the meeting.
Read moreACR Gears Up For Key State Legislative Issues Including AI
ACR joined physician leaders at the AMA summit to address Medicaid, payer issues, physician-led care, wellness, and emerging AI legislation in states.
Read more